Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
Alfonso Dueñas‐González(Instituto Nacional de Cancerología), Mauro Orlando(Instituto Alexander Fleming)
Cited by 479
Related Papers
Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer
|Cancer Cell International|2006|35